Comparison of outcomes following a switch from a brand to an authorized vs. independent generic drug.
about
Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System Drugs.Medication changes after switching from CONCERTA® brand methylphenidate HCl to a generic long-acting formulation: A retrospective database study.Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study.
P2860
Comparison of outcomes following a switch from a brand to an authorized vs. independent generic drug.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Comparison of outcomes followi ...... vs. independent generic drug.
@en
Comparison of outcomes followi ...... vs. independent generic drug.
@nl
type
label
Comparison of outcomes followi ...... vs. independent generic drug.
@en
Comparison of outcomes followi ...... vs. independent generic drug.
@nl
prefLabel
Comparison of outcomes followi ...... vs. independent generic drug.
@en
Comparison of outcomes followi ...... vs. independent generic drug.
@nl
P2093
P2860
P356
P1476
Comparison of Outcomes Followi ...... ersus Independent Generic Drug
@en
P2093
E Seoane-Vazquez
J G Linneman
P L Peissig
R A Hansen
P2860
P304
P356
10.1002/CPT.591
P407
P577
2016-12-16T00:00:00Z